Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole A Sable

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Annual Review of Medicine|October 31, 2007
Advances in antifungal therapyCarole A Sable, Kim M Strohmaier, Jeffrey A Chodakewitz
The Journal of Infection|May 24, 2005
Invasive candidiasis in cancer patients: observations from a randomized clinical trialMark J DiNubile, Darcy Hille, Carole A Sable, et al.
AIDS Research and Human Retroviruses|September 17, 2002
Response and relapse rates of candidal esophagitis in HIV-infected patients treated with caspofunginMark J Dinubile, Robert J Lupinacci, Rayanne S Berman, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2004
Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use studyNicholas A Kartsonis, Alfred Saah, C Joy Lipka, et al.
Journal of Critical Care|September 18, 2007
Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trialMark J DiNubile, Robert J Lupinacci, Kim M Strohmaier, et al.
The Journal of Infection|March 23, 2005
Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use studyNicholas A Kartsonis, Alfred J Saah, C Joy Lipka, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazoleNicholas Kartsonis, Mark J DiNubile, Ken Bartizal, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiasesEduardo G Arathoon, Eduardo Gotuzzo, L Miguel Noriega, et al.
Natural Product Reports|November 26, 2013
Discovery and development of first in class antifungal caspofungin (CANCIDAS®)--a case studyJames M Balkovec, David L Hughes, Prakash S Masurekar, et al.
The American Journal of Medicine|October 4, 2002
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasisAlvaro Villanueva, Eduardo Gotuzzo, Eduardo G Arathoon, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Annual Review of Medicine|October 31, 2007
Advances in antifungal therapyCarole A Sable, Kim M Strohmaier, Jeffrey A Chodakewitz
The Journal of Infection|May 24, 2005
Invasive candidiasis in cancer patients: observations from a randomized clinical trialMark J DiNubile, Darcy Hille, Carole A Sable, et al.
AIDS Research and Human Retroviruses|September 17, 2002
Response and relapse rates of candidal esophagitis in HIV-infected patients treated with caspofunginMark J Dinubile, Robert J Lupinacci, Rayanne S Berman, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2004
Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use studyNicholas A Kartsonis, Alfred Saah, C Joy Lipka, et al.
Journal of Critical Care|September 18, 2007
Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trialMark J DiNubile, Robert J Lupinacci, Kim M Strohmaier, et al.
The Journal of Infection|March 23, 2005
Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use studyNicholas A Kartsonis, Alfred J Saah, C Joy Lipka, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazoleNicholas Kartsonis, Mark J DiNubile, Ken Bartizal, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiasesEduardo G Arathoon, Eduardo Gotuzzo, L Miguel Noriega, et al.
Natural Product Reports|November 26, 2013
Discovery and development of first in class antifungal caspofungin (CANCIDAS®)--a case studyJames M Balkovec, David L Hughes, Prakash S Masurekar, et al.
The American Journal of Medicine|October 4, 2002
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasisAlvaro Villanueva, Eduardo Gotuzzo, Eduardo G Arathoon, et al.
Pageof 2